MOUNTAIN VIEW, Calif., July 17, 2012 /PRNewswire/ -- Xlumena, Inc. announces that it has received CE Mark approval to market its AXIOS Stent and Delivery System for biliary tract drainage.

The first stent specifically designed to treat pancreatic pseudocysts yesterday was cleared for marketing by the US Food and Drug Administration (FDA). The Axios stent and delivery system from ...

In a bid to extend its footprint in the multibillion-dollar endoscopy equipment market, Boston Scientific Corporation BSX has commercially launched its FDA-cleared Axios stent and electrocautery ...

MOUNTAIN VIEW, Calif., May 15, 2012 /PRNewswire/ -- Xlumena, Inc. announces the publication of a scientific paper describing the first human study of the AXIOS™ Stent and Delivery System.

Boston Scientific Corporation announced today the commercial launch of the AXIOS Stent and Electrocautery Enhanced Delivery System. It is designed to help physicians manage serious complications ...

(HealthDay News) – The AXIOS Stent and Delivery System has been approved by the U.S. Food and Drug Administration to treat pancreatic pseudocysts, the FDA said in a news release. The AXIOS stent ...

The Axios stent is a wire mesh tube that can expand to more than 1/2-inch diameter. It was evaluated among 33 clinical study participants who had a pancreatic pseudocyst at least six centimeters ...

Here are six recent news updates on key gastroenterology and endoscopy companies. Boston Scientific launched the AXIOS Stent and Electrocautery Enhanced Delivery System. SonarMD entered into a ...

According to Boston Scientific, M.I.Tech’s product offerings complement the company’s existing stent portfolio, including the differentiated AXIOS Stent and Electrocautery Enhanced Delivery ...

In a bid to extend its footprint in the multibillion-dollar endoscopy equipment market, Boston Scientific Corporation BSX has commercially launched its FDA-cleared Axios stent and electrocautery ...

The Axios Stent and Delivery System has been approved by the U.S. Food and Drug Administration to treat infected pancreatic cysts that won't drain on their own and could become life threatening ...